<p>Neumora Therapeutics Inc. has announced the issuance of 2,849,327 shares of common stock to K2 HealthVentures Equity Trust LLC. This transaction follows the receipt of a conversion notice from K2 HealthVentures, which elected to convert $2.5 million of the outstanding principal under a term loan into common stock at a conversion price of $0.8774 per share. The shares were issued as unregistered securities under the exemption provided by Section 4(a)(2) of the Securities Act of 1933. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neumora Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-291352), on November 21, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

NMRA

<p>Neumora Therapeutics Inc. issued 2,849,327 shares of common stock to K2 HealthVentures Equity Trust LLC after K2 converted $2.5 million of a term loan into common stock at $0.8774 per share. The shares were issued as unregistered securities under Section 4(a)(2) of the Securities Act of 1933.</p>

Neumora Therapeutics Issues 2.85 Million Shares to K2 HealthVentures in Loan Conversion